TechnoPhage, SA - From science to innovative biopharmaceuticals
Labiotech.eu highlighted TechnoPhage as one of the top 15 biotech companies in Portugal. Click here to read the article.
Our Head of Infection, Clara Leandro, will attend the 1st Bacteriophage Therapy Summit in Boston between 25 and 27 of March. She will be one of the experts that will discuss how bacteriophage therapy can quickly become a reality for patients who are in need of alternative antimicrobial treatments.
PRESS RELEASE Ontem, dia 15 de janeiro de 2019, foi assinada a constituição da Associação, VectorB2B – Drug Developing – Associação para Investigação em Biotecnologia. O Vector B2B resultou da iniciativa partilhada de sete entidades, o Laboratório Medinfar, S.A., a BEVAG, a Faculdade de Medicina, a Faculdade de Farmácia e a Faculdade de…
Technophage was present at the 3rd edition of the "Innovation Sessions" event held in Brussels on 4 June 2018 at the European Economic and Social Council. This edition of the event was dedicated to the theme "Healthcare Systems and Future Therapies", and was attended by several speakers, Portuguese and international, from all areas…

2019 events

Phage Futures Europe
Brussels, Belgium, September 25-26, 2019